2.7.3.2	panaxadiol	15.4% increase of activity at 0.08 mM	760706	
2.7.3.2	24-carboxy-protopanaxadiol	17.3% increase of activity at 0.005 mM	760706	
2.7.3.2	20(R)-protopanaxadiol	23.5% increase of activity at 0.02 mM	760706	
2.7.3.2	25-hydroxy-protopanaxadiol	23.5% increase of activity at 0.02 mM	760706	
2.7.3.2	ginsenoside Rh2	3.5% increase of activity at 0.04 mM	760706	
2.7.3.2	20(S)-protopanaxatriol	32.2% increase of activity at 0.02 mM	760706	
2.7.3.2	ADP	activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine	674713	
2.7.3.2	ATP	activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine	674713	
2.7.3.2	Creatine	activation of creatine kinase and induction of a state 3-like respiration in isolated brain mitochondria, and prevention of H2O2 production obeys the steady-state kinetics of the enzyme to phosphorylate creatine	674713	
2.7.3.2	olanzapine	activation of enzyme in striatum after chronic administration at 10 mg/kg	671679	
2.7.3.2	aripiprazole	activation of enzyme in striatum and cerebral cortex after chronic administration at 10 or 20 mg/kg. No effect on enzyme in hippocampus, cerebellum and prefrontal cortex	671679	
2.7.3.2	trans-[RuCl2(3,4-pyridinedicarboxylic acid)4]	administration at 180.7 micromol/kg, increase of creatine kinase activity in hippocampus, striatum, cerebral cortex and heart, but not in skeletal muscle. No effect on enzyme in vitro	675240	
2.7.3.2	trans-[RuCl2(3,5-pyridinedicarboxylic acid)4]	administration at 180.7 micromol/kg, increase of creatine kinase activity in hippocampus, striatum, cerebral cortex and heart, but not in skeletal muscle. No effect on enzyme in vitro	675240	
2.7.3.2	20(S)-protopanaxadiol	best activator	760706	
2.7.3.2	20(S)-protopanaxadiol	best activator of isoform CK-MM, 54.3% increase of activity at 0.04 mM	760706	
2.7.3.2	additional information	increase of enzymatic activity post-exercise	697687	
2.7.3.2	NADH	lowers Km for phosphocreatine 3fold	642417	
2.7.3.2	additional information	not influenced by panaxatriol, ocotillol, ginsenoside Rg1, and ginsenoside Rd	760706	
2.7.3.2	additional information	panaxatriol, ocotillol, ginsenoside Rg1, and ginsenoside Rd have no significant influence on the enzyme activity	760706	
2.7.3.2	20(R)-protopanaxadiol	significantly increases the enzyme activity	760706	
2.7.3.2	20(S)-protopanaxatriol	significantly increases the enzyme activity	760706	
2.7.3.2	24-COOH-protopanaxadiol	significantly increases the enzyme activity	760706	
2.7.3.2	25-OH-protopanaxadiol	significantly increases the enzyme activity	760706	
2.7.3.2	ginsenoside Rh2	significantly increases the enzyme activity	760706	
2.7.3.2	panaxadiol	significantly increases the enzyme activity	760706